Who Attends

 

Big Pharma

Head of Business Development, Search & Evaluation or External Innovation for Oncology & Immunology:

This forum offers the opportunity for:

  • Evaluation and comparison of related assets, pipelines, and platforms
  • Understanding of relevant scientific context to validate innovations and support strategic decision-making
  • A boutique touchpoint for follow-up outside of larger forums, with more time to give detailed guidance and feedback, and more manageable meeting schedules.

“I liked the format it meant the companies knew what Sanofi was looking for and made the 30-minute meetings very efficient.”

Sanofi, Neuroscience Innovation Partnering & Licensing Summit 2025

 

 

Biotech

Founders, C-Suite, Heads of Business Development

Ensuring relevant exposure, biotech join this different format to:

  • Network more efficiently with less competition to engage with key stakeholders
  • Understand positioning and pitches of competitors to sharpen own differentiation
  • Gain multiple 1-2-1 meetings for feedback on data packages and interest

“There was great engagement from pharma and investors with an interest in advancing assets like ours”

CBO, 2md Neuroscience Innovation Partnering & Licensing Summit 2026

 

 

Investors

Corporate Venture & Venture Capital

Connecting investors to both pharma and biotech teams, this unique opportunity allows investors to:

  • Understand pharma’s reception to innovation developed by leading biotech to inform portfolio direction and exit strategies
  • Efficiently gain landscape updates and information from private biotech

“The high seniority and high quality of participants made it easier than usual to get a meeting with the right people, primarily pharma.”

Investor, Neuroscience Innovation Partnering & Licensing Summit 2025

 

Audience at Oncology & Immunology Innovation Partnering

Review the Program

Confidently evaluate if this targeted networking opportunity aligns with your partnering objectives. Review the format, speaker faculty, and remaining presentation sessions in the full event guide.

Networking at Oncology & Immunology Innovation Partnering

Become a Founding Partner

If you’re a law firm, bank, or offer-omics, CRO, or CDMO services and you’re looking for a differentiated and near-exclusive opportunity to associate your brand awareness with high-value interactions, review information about becoming a founding partner here.

Speaker at Oncology & Immunology Innovation Partnering

Register to Join

Bridging the gap between innovative R&D and partnership conversations: deliberately timed between BIO and JPM. Register for early-bird discounts, secure a presentation opportunity whilst they last, and share your company logo with us to advertise your attendance on this website.